|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Zyga Technology Secures $25,000,000 Series C Funding Round
|
VentureDeal |
05/17/12 |
Detroit
|
|
WaveTec Vision Systems Lands $16,500,000 New Financing
|
VentureDeal |
04/10/12 |
San Diego
|
|
Glaxo and J&J’s Shrewd Move Will Help the Biotech Ecosystem
|
Troy Wilson |
03/23/12 |
National
|
|
Biotech’s New Frontier: Europe?
|
Luke Timmerman |
03/19/12 |
National
|
|
Sequent Medical Receives $26,000,000 Series C Round
|
VentureDeal |
03/07/12 |
San Diego
|
|
San Diego Life Sciences Roundup: Receptos, Vital Therapies, & More
|
Bruce V. Bigelow |
02/23/12 |
San Diego
|
|
Join Kevin Starr, Corey Goodman, Carl Weissman & More in Seattle April 3
|
Luke Timmerman |
01/19/12 |
Seattle
|
|
FDA’s Shuren Makes West Coast Swing, Talks About Regulatory Reform
|
Bruce V. Bigelow |
01/18/12 |
National
|
|
A Sweet Deal: How Amira Reinvented Itself as a Drug Discovery Engine
|
Bruce V. Bigelow |
12/23/11 |
San Diego
|
|
Groove Biopharma Snags $6M to Push the Frontiers With MicroRNA Drugs
|
Luke Timmerman |
12/12/11 |
Seattle
|
|
Groove Biopharma Receives $8,000,000 Series B Financing
|
VentureDeal |
12/12/11 |
Seattle
|
|
AcuFocus Lands $65,000,000 New Funding Round
|
VentureDeal |
11/30/11 |
San Diego
|
|
Fresh Off Amira Success, Versant’s Bolzon and San Diego’s Prasit Begin Anew with Inception
|
Bruce V. Bigelow |
11/29/11 |
San Diego
|
|
Versant Ventures’ Partner Cuts Back on Biotech Work to Spend Time With Family. For Real
|
Luke Timmerman |
11/28/11 |
National
|
|
Veracyte Finds a Way to Make a Buck Cutting Waste in Thyroid Cancer Treatment
|
Luke Timmerman |
11/18/11 |
San Francisco
|
|
Five Things Industry Can Do to Support True FDA Reform, and Restore Public Confidence
|
Luke Timmerman |
10/10/11 |
National
|
|
Light Sciences Stumbles, Cardiac Dimensions Gets EU OK, Immune Design Pockets $11M, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
10/06/11 |
Seattle
|
|
Immune Design Rakes In Another $11M From Prior VC Round
|
Luke Timmerman |
10/05/11 |
Seattle
|
|
Amira Pharma on How it Beat the Odds, and Sold an Early Stage Drug to Bristol-Myers for $325M
|
Luke Timmerman |
09/07/11 |
San Diego
|
|
Intuity Medical Garners $76,000,000 Series D Funding
|
VentureDeal |
08/02/11 |
San Francisco
|
|
Bristol-Myers Acquires Amira Pharmaceuticals for $325 Million, Scoops Up Lung Drug
|
Luke Timmerman |
07/21/11 |
San Diego
|
|
$26M for Minerva Surgical
|
Wade Roush |
06/06/11 |
San Francisco
|
|
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/28/11 |
San Diego
|
|
VCs Turn Up The Heat on FDA to Get Faster, More Predictable
|
Luke Timmerman |
04/25/11 |
National
|
|
West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
04/21/11 |
San Diego
|
|
In This Corner: Kinsella & More Vs. Hutton & Samuels on Venture Biotech
|
Bruce V. Bigelow |
04/18/11 |
San Diego
|
|
BenVenue Medical Receives $35,500,000 Series C Financing
|
VentureDeal |
04/18/11 |
San Francisco
|
|
Medivation Flunks Huntington’s Trial, Calibra Nabs Venture Cash, Open Source Biology Comes to SF, & More Bay Area Life Sciences News
|
Luke Timmerman |
04/15/11 |
San Francisco
|
|
Open Source Biology’s Moment, Mirador Advances the Runner, Allen’s Latest Brain Map, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
04/14/11 |
Seattle
|
|
Mirador Biomedical, Playing ‘Small Ball’ in Medical Devices, Pockets $1.5M Financing
|
Luke Timmerman |
04/13/11 |
Seattle
|
|
Page 1 of
5 |
next page » |
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.